Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Total Non-Current Liabilities (2016 - 2018)

Historic Total Non-Current Liabilities for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to $3.6 million.

  • Armata Pharmaceuticals' Total Non-Current Liabilities fell 33.11% to $3.6 million in Q3 2018 from the same period last year, while for Sep 2018 it was $3.6 million, marking a year-over-year decrease of 33.11%. This contributed to the annual value of $3.1 million for FY2017, which is 4797.06% down from last year.
  • According to the latest figures from Q3 2018, Armata Pharmaceuticals' Total Non-Current Liabilities is $3.6 million, which was down 33.11% from $3.2 million recorded in Q2 2018.
  • In the past 5 years, Armata Pharmaceuticals' Total Non-Current Liabilities ranged from a high of $69.5 million in Q1 2014 and a low of $2.9 million during Q1 2018
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $6.0 million (2016), whereas its average is $13.9 million.
  • Data for Armata Pharmaceuticals' Total Non-Current Liabilities shows a peak YoY increase of 1107.61% (in 2016) and a maximum YoY decrease of 7666.19% (in 2016) over the last 5 years.
  • Armata Pharmaceuticals' Total Non-Current Liabilities (Quarter) stood at $17.4 million in 2014, then tumbled by 68.96% to $5.4 million in 2015, then increased by 11.08% to $6.0 million in 2016, then plummeted by 47.97% to $3.1 million in 2017, then grew by 15.96% to $3.6 million in 2018.
  • Its Total Non-Current Liabilities was $3.6 million in Q3 2018, compared to $3.2 million in Q2 2018 and $2.9 million in Q1 2018.